102 related articles for article (PubMed ID: 2959231)
1. [Effects of conversion enzyme inhibitors on the synthesis of angiotensin II by the isolated rat kidney].
Krieger JP; Welsch C; Giesen-Crouse E; Schmidt M; Imbs JL
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):862-5. PubMed ID: 2959231
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
3. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
[TBL] [Abstract][Full Text] [Related]
4. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
5. Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.
Riddle MC; McDaniel PA
J Clin Endocrinol Metab; 1994 Apr; 78(4):830-4. PubMed ID: 8157707
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
Saito H; Nakamaru M; Rakugi H; Mikami H; Ogihara T; Inagami T
Clin Exp Pharmacol Physiol; 1990 Nov; 17(11):745-53. PubMed ID: 2150362
[TBL] [Abstract][Full Text] [Related]
7. Intrarenal generation of angiotensin II evaluated by an electrophysiological technique.
Bührle CP; Rosivall L; Taugner R
Am J Physiol; 1987 Apr; 252(4 Pt 2):F635-44. PubMed ID: 2952019
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
10. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
11. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
12. [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
Meyer-Lehnert H; Jahnecke C; Kappes-Horn K; Kramer HJ
Klin Wochenschr; 1991; 69 Suppl 24():45-9. PubMed ID: 1650862
[TBL] [Abstract][Full Text] [Related]
13. In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase.
Grima M; Welsch C; Michel B; Barthelmebs M; Imbs JL
Hypertension; 1991 Apr; 17(4):492-6. PubMed ID: 2013476
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
15. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.
van Gilst WH; de Graeff PA; Wesseling H; de Langen CD
J Cardiovasc Pharmacol; 1986; 8(4):722-8. PubMed ID: 2427810
[TBL] [Abstract][Full Text] [Related]
16. Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms.
Collis MG; Keddie JR
Clin Sci (Lond); 1981 Sep; 61(3):281-6. PubMed ID: 7021045
[TBL] [Abstract][Full Text] [Related]
17. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
Bender N; Rangoonwala B; Rosenthal J; Vasmant D
Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
[TBL] [Abstract][Full Text] [Related]
19. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
Chiba S; Quilley CP; McGiff JC
Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
[TBL] [Abstract][Full Text] [Related]
20. Reversal by acetylsalicylic acid of the captopril-induced inhibition of angiotensin converting enzyme in the hindquarters of guinea-pig.
Melli M; Türker RK
Arch Int Pharmacodyn Ther; 1982 May; 257(1):87-93. PubMed ID: 6287951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
